Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service
Autor: | Helen Bell, Fotinie Ntziora, Dawn Andrews, Oyewole Christopher Durojaiye, Katharine Cartwright |
---|---|
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
Microbiology (medical) medicine.medical_specialty Cost effectiveness Cost-Benefit Analysis 030106 microbiology Communicable Diseases 03 medical and health sciences 0302 clinical medicine Patient satisfaction Surveys and Questionnaires medicine Ambulatory Care Humans Pharmacology (medical) Infusions Parenteral 030212 general & internal medicine Clinical efficacy Intensive care medicine Home Infusion Therapy Retrospective Studies Cross Infection Inpatient care business.industry Soft Tissue Infections Parenteral antibiotic General Medicine Health Care Costs Patient Acceptance of Health Care United Kingdom Anti-Bacterial Agents Infectious Diseases Treatment Outcome Patient Satisfaction Cost analysis Electronic database National average business |
Zdroj: | International journal of antimicrobial agents. 51(1) |
ISSN: | 1872-7913 |
Popis: | Outpatient parenteral antimicrobial therapy (OPAT) has evolved relatively slowly in the UK. This study describes the OPAT service based in a large UK teaching hospital in Sheffield, and examines the clinical efficacy, patient acceptability and costs saved over a 10-year period. Data on 3812 episodes of OPAT treatment administered between January 2006 and January 2016 were retrieved from a prospectively maintained electronic database. This study compared the real costs of the OPAT service with estimated costs of conventional inpatient care for these patient episodes, and analysed patient feedback questionnaires that were administered randomly between January 2014 and January 2015. A wide range of infections were managed during the 10-year period. Skin and soft tissue infections accounted for 57% of OPAT episodes. The total number of bed-days saved was 49 854. A successful outcome (cure or improvement) was found in 3357 (88%) episodes. Re-admission occurred in 265 (7%) episodes. The rates of healthcare-associated infections were low: 15 intravenous-line-related infections were recorded (0.3 per 1000 OPAT patient-days). Patient acceptance and satisfaction with OPAT were high. OPAT cost 15%, 39%, 40% and 44% of inpatient costs for an infectious diseases unit, national average costs, other departments (non-infectious diseases unit), and the minimum national average costs for each diagnostic category, respectively. This study shows that OPAT is safe, clinically efficacious and acceptable for treating a wide range of infections with high levels of patient satisfaction and substantial cost savings. |
Databáze: | OpenAIRE |
Externí odkaz: |